Brown, Lisle/Cummings’s Chemours CC Stock Holding History

Brown, Lisle/Cummings’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.5K	Hold	613	–	–	﹤0.01%	525
2025 Q4	$7.23K	Hold	613	–	–	﹤0.01%	524
2025 Q3	$9.71K	Hold	613	–	–	﹤0.01%	505
2025 Q2	$7.02K	Buy	613 +481	+364%	+$5.42K	﹤0.01%	536
2025 Q1	$1.79K	Hold	132	–	–	﹤0.01%	658
2024 Q4	$2.23K	Sell	132 -40	-23%	-$778	﹤0.01%	599
2024 Q3	$3.5K	Hold	172	–	–	﹤0.01%	542
2024 Q2	$3.88K	Hold	172	–	–	﹤0.01%	527
2024 Q1	$4.52K	Hold	172	–	–	﹤0.01%	489
2023 Q4	$5.42K	Buy	172 +132	+330%	+$3.58K	﹤0.01%	485
2023 Q3	$1.12K	Hold	40	–	–	﹤0.01%	529
2023 Q2	$1.48K	Hold	40	–	–	﹤0.01%	526
2023 Q1	$1.2K	Hold	40	–	–	﹤0.01%	511
2022 Q4	$1.23K	Buy	+40	New	+$1.2K	﹤0.01%	497
2022 Q2	–	Sell	-600	Closed	-$18.9K	–	482
2022 Q1	$18.9K	Hold	600	–	–	0.01%	340
2021 Q4	$20.1K	Buy	+600	New	+$18.7K	0.01%	337

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

WHCM

Wolf Hill Capital Management Greenwich, Connecticut $1.2B AUM 137.35% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Brown, Lisle/Cummings's CC Position: Q1 2026 in Review

Brown, Lisle/Cummings held its Chemours (CC) position steady in Q1 2026 at 613 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #525.

Brown, Lisle/Cummings first reported a position in CC in Q4 2021 and has held it in 16 quarters since. The position peaked at $20.1K in Q4 2021. 450 funds tracked by Wall St. Rank hold CC as of Q1 2026.

Brown, Lisle/Cummings held 613 shares of Chemours worth $13.5K as of Q1 2026.
Brown, Lisle/Cummings left its Chemours share count unchanged in Q1 2026.
Chemours made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #525 holding.
Brown, Lisle/Cummings first reported a position in Chemours in Q4 2021 and has held it in 16 quarters since.
Brown, Lisle/Cummings's Chemours position peaked at $20.1K in Q4 2021.
450 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.